M-Vax - Autologous Cell Melanoma Vaccine
Avax Technologies, Inc
Clinical trials and investigators are
Robert J. Belt, Principal Investigator, Ph: 816-531-2740 Midwest Oncology Consortium Kansas City, Missouri, USA Kevin P. Hubbard, Principal Investigator, Ph: 816-454-1658 University of Health Sciences Kansas City, Missouri, USA Joseph Germino, Principal Investigator, Ph: 732-235-7955 Cancer Institute of New Jersey New Brunswick, New Jersey, USA Peter Mencel, Principal Investigator, Ph: 908-528-0760 Jersey Shore Cancer Center Neptune, New Jersey, USA Bernard Bernhardt, Principal Investigator, Ph: 914-632-5397 Advanced Oncology Associates White Plains, New York, USA Robert L. Fine, Principal Investigator, Ph: 212-305-1168 Herbert Irving Comprehensive Cancer Center New York, New York, USA Dennis Franklin Devereux, Principal Investigator, Ph: 914-437-3113 Vassar Brothers Hospital Poughkeepsie, New York, USA Thomas E. Olencki, Principal Investigator, Ph: 216-444-7774 Cleveland Clinic Cancer Center Cleveland, Ohio, USA Leonard J. Horwitz, Principal Investigator, Ph: 513-861-0600 Medical Oncology/Hematology Cincinnati, Ohio, USA Paul L. Schaefer, Principal Investigator, Ph: 419-479-5605 Toledo Clinic, Inc. Toledo, Ohio, USA David Berd, Principal Investigator, Ph: 215-955-8875 Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, USA Lynn Mara Schuchter, Principal Investigator, Ph: 215-662-7907 University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, USA